The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

22 Jul 2020 07:00

RNS Number : 6846T
Quixant PLC
22 July 2020
 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

22 July 2020

Quixant plc

("Quixant" or the "Company" or the "Group")

 

Trading update and Notice of Results

 

Solid net cash position supported by robust Densitron trading

 

Quixant (AIM: QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, is pleased to provide an update on trading for the six months ended 30 June 2020 (the "Period").

 

The board is pleased with the performance of Densitron, the Group's business unit specialising in human machine interaction for markets outside gaming. Densitron has experienced healthy demand from a range of industrial sectors during the Period with a highlight being the medical market which has seen elevated demand from new and existing customers for our range of display products. This sector represents an exciting growth area for the Group and management is actively exploring further organic growth opportunities. Additional strategic business wins in the broadcast sector with customers such as Panasonic leave Densitron well-positioned for growth as the economy emerges from lockdown.

 

Gaming, which is the key market for the Group, has seen only minimal orders during the past three months, with most of the Group's gaming clients closed due to the Covid-19 pandemic. Casinos and other gaming venues, however, started to reopen during the latter part of the second quarter and, whilst the speed of recovery of this part of the Group's revenues cannot be predicted, the Group has seen an improvement in activity in June. The downturn in revenues has been mitigated by the implementation of a swift overhead cost reduction programme and a streamlining of the Group's product base which, whilst thorough, have been implemented so as to both leave the Group well-positioned to support customers in their recovery and also explore new opportunities for growth.

 

The board is also pleased with the Group's working capital position in the Period. Densitron's robust trading performance combined with strong collection of receivables from the Group's gaming customers and the benefits of a swiftly executed cost management programme has yielded a solid net cash position at 30 June 2020 of $14.2m (31 December 2019: $16.1m). The Group also has additional unutilised lines of credit of over $12.4m, including a new $9.4m UK Government-backed Barclays revolving credit facility, should additional facilities be required.

 

The board expects to announce its results for the six months ended 30 June 2020 on 30 September 2020.

 

Jon Jayal, Chief Executive of Quixant, commented: 

 

"Given the economic circumstances, I am pleased with the performance of the Group in the first six months of the financial year. Our Densitron business, which celebrates its 50-year anniversary in 2020 has performed well and has demonstrated the benefits of a diverse revenue base, and an ability to withstand economic shocks.

 

"Our strong net cash position entering the pandemic has remained largely intact, supported by robust Densitron trading, a swiftly executed cost reduction programme and sustained cash collection from our gaming customers, who have appreciated the flexibility and partnership we have offered them in this challenging period. I am pleased to see some early signs of activity beginning to return for some of our gaming clients.

 

"Quixant's strength of customer relationships and flexibility of approach has enabled the Group to drive some exciting evolutions in our offering and business model during the past few months. This, combined with our solid balance sheet, places the Company in a strong position to grow over the longer term."

 

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Executive Officer

Guy Millward, Chief Financial Officer 

 

 

 

 

 

Nominated Adviser and Broker:

 

finnCap Ltd

Tel: +44(0)20 7220 0500

Matt Goode / Simon Hicks (Corporate Finance)

 

Alice Lane (Corporate Broking) 

 

 

 

 

Financial PR:

Tel: +44 (0) 20 3405 0205

Alma PR

 

John Coles / Susie Hudson / David Ison / Kieran Breheny

 

   

 

About Quixant

 

Quixant, founded in 2005, was established as a designer and manufacturer of highly optimised computing solutions and display solutions for the global gaming industry. Through the acquisition of Densitron Technologies plc in 2015, the Company diversified into other markets and has a focused technology offering for the broadcast sector, leveraging the business' extensive sector knowledge across many industries.

 

The Company is headquartered in Cambridge in the UK, with a global customer base and offices in North America, Europe and Asia. The Taiwanese operation is responsible for design, procurement and manufacturing of the Company's products. Quixant owns all its IP, some of which is protected by patents and design rights.

 

In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKZGZNRMRGGZM
Date   Source Headline
27th Apr 20234:53 pmRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement and Proposed Name Change
14th Apr 20237:00 amRNSExercise of options
4th Apr 20237:00 amRNSReport and Accounts and Notice of AGM
3rd Apr 20235:52 pmRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of Options
21st Mar 20237:00 amRNSFinal Results
21st Feb 20237:00 amRNSNotice of Results and Investor Presentation
17th Jan 20238:15 amRNSExercise of options
16th Jan 20237:00 amRNSTrading Update and Notice of Results
13th Jan 20238:59 amRNSHolding(s) in Company
3rd Nov 202212:09 pmRNSDirector Shareholding
26th Oct 20228:20 amRNSDirector Shareholding
14th Oct 20227:23 amRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
13th Sep 20227:00 amRNSAppointment of Non-Executive Directors
6th Sep 20227:00 amRNSInterim Results
1st Sep 20227:00 amRNSMass production order for gaming cabinet solutions
31st Aug 20227:00 amRNSNotice of Results and Presentations
14th Jul 20227:00 amRNSTrading Update and Notice of Results
9th May 20226:04 pmRNSGrant of Options
5th May 202211:55 amRNSResult of AGM
5th May 20227:00 amRNSAGM Statement
11th Apr 202211:37 amRNSReport and Accounts and Notice of AGM
5th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSNotice of Results and Presentations
9th Mar 20222:06 pmRNSSecond Price Monitoring Extn
9th Mar 20222:00 pmRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Update and Notice of Results
29th Oct 20212:28 pmRNSGrant of Options
22nd Sep 20217:00 amRNSInterim Results
15th Sep 20217:00 amRNSInvestor Presentation
5th Aug 202111:16 amRNSHolding(s) in Company
29th Jul 20217:00 amRNSTrading Update and Notice of Results
12th Jul 20213:02 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSAppointment of CFO
1st Jul 20217:00 amRNSDirector Shareholding
6th May 20215:12 pmRNSResult of AGM
6th May 20217:00 amRNSAGM Statement
19th Apr 20216:07 pmRNSHolding(s) in Company
19th Apr 20215:48 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSFinal Results
9th Apr 20214:40 pmRNSRescheduled Investor Presentation
9th Apr 20213:41 pmRNSAnnouncement of Final Results
6th Apr 20217:00 amRNSInvestor Presentation
26th Feb 20217:00 amRNSNotice of Results
12th Feb 20217:00 amRNSAppointment of Joint Broker
27th Jan 20217:00 amRNSTrading Update and Notice of Results
15th Jan 20217:00 amRNSAppointment of New Senior Independent NED
10th Dec 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.